AlphaCore Capital’s Aurora Cannabis ACB Stock Holding History

AlphaCore Capital’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-45	Closed	-$5K	–	73
2020 Q1	$5K	Buy	+45	New	+$8.04K	﹤0.01%	248

Other funds holding ACB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

AlphaCore Capital's ACB Position: Q2 2020 in Review

AlphaCore Capital sold out of Aurora Cannabis (ACB) in Q2 2020, closing a stake of 45 shares — an estimated $5K sold.

AlphaCore Capital first reported a position in ACB in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 235 funds tracked by Wall St. Rank hold ACB as of Q2 2020.

AlphaCore Capital reported no remaining Aurora Cannabis position as of Q2 2020 after selling out during the quarter.
AlphaCore Capital sold 45 Aurora Cannabis shares in Q2 2020, an estimated $5K.
AlphaCore Capital first reported a position in Aurora Cannabis in Q1 2020 and held it in 1 quarter.
AlphaCore Capital's Aurora Cannabis position peaked at $5K in Q1 2020.
235 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2020.

Based on AlphaCore Capital's 13F filing for Q2 2020, filed 14 Aug 2020.